ストックスクリーナーアプリを入手
28.75
1.66%
0.47
アフターアワーズ：
28.75
前日終値:
$28.28
開ける：
$28.34
24時間の取引高:
87,453
Relative Volume:
0.47
時価総額：
$844.28M
収益：
$4.12M
当期純損益:
$-56.68M
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
$-51.44M
1週間 パフォーマンス:
+3.60%
1か月 パフォーマンス:
+2.68%
6か月 パフォーマンス:
+11.43%
1年 パフォーマンス:
+139.58%
1日の値動き範囲:
$28.14
$29.19
1週間の範囲:
$27.41
$29.19
52週間の値動き範囲:
$6.58
$33.77
Dianthus Therapeutics Inc Stock (DNTH) Company Profile
名前
Dianthus Therapeutics Inc
セクター
電話
857-201-2700
住所
300 TECHNOLOGY SQUARE, CAMBRIDGE
Dianthus Therapeutics Inc Stock (DNTH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-26 | 開始されました | Robert W. Baird | Outperform |
| 2024-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-05-16 | 開始されました | H.C. Wainwright | Buy |
| 2024-02-15 | 開始されました | Stifel | Buy |
| 2023-12-26 | 開始されました | Jefferies | Buy |
| 2023-11-22 | 開始されました | Wedbush | Outperform |
| 2023-10-30 | 開始されました | Guggenheim | Buy |
| 2023-09-28 | 開始されました | Raymond James | Outperform |
| 2022-08-25 | ダウングレード | Goldman | Buy → Neutral |
| 2022-01-06 | アップグレード | Goldman | Neutral → Buy |
| 2021-08-20 | 再開されました | Goldman | Neutral |
| 2021-08-03 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-22 | 繰り返されました | B. Riley Securities | Buy |
| 2021-06-29 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-06-15 | 開始されました | BTIG Research | Buy |
| 2021-05-18 | 開始されました | B. Riley Securities | Buy |
| 2021-01-07 | 開始されました | Mizuho | Buy |
| 2020-06-08 | アップグレード | Goldman | Neutral → Buy |
| 2019-03-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-03-15 | 開始されました | Raymond James | Outperform |
すべてを表示
Dianthus Therapeutics Inc (DNTH) 最新ニュース
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences - The Manila Times
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences - GlobeNewswire Inc.
Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
SG Americas Securities LLC Increases Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 5%Should You Buy? - MarketBeat
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting - The Manila Times
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Down 4.4%Here's What Happened - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Receives $45.13 Consensus Target Price from Brokerages - MarketBeat
Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.7% Jump Turn into More Strength? - Yahoo Finance
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 4.5% – Still a Buy? - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Stock Price Up 4.5%Should You Buy? - MarketBeat
Dianthus: Modest Opportunity With 2 Caveats (NASDAQ:DNTH) - Seeking Alpha
Dianthus Therapeutics (NASDAQ:DNTH) Shares Down 5.7%Here's Why - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Sees Unusually-High Trading Volume – Still a Buy? - Defense World
Marshall Wace LLP Sells 4,731 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dianthus started at outperform by Oppenheimer on DNTH103 opportunity - MSN
Dianthus started at outperform by Oppenheimer on DNTH103 opportunity (NASDAQ:DNTH) - Seeking Alpha
Oppenheimer Initiates Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Shares Sold by Point72 Asset Management L.P. - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Shares Gap Down to $27.88 - Defense World
Renaissance Technologies LLC Lowers Stake in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
American Century Companies Inc. Increases Stock Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Fred Alger Management LLC Has $163,000 Holdings in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Rating Reiterated by HC Wainwright - MarketBeat
Expert Ratings For Dianthus Therapeutics - Benzinga
Point72 Asia Singapore Pte. Ltd. Acquires 29,159 Shares of Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Point72 Asia Singapore Pte. Ltd. Has $1.02 Million Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Insider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) Director Sells 40,831 Shares of Stock - Defense World
Dirk Kersten Sells 79,411 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock - Defense World
Logos Global Management LP Sells 1,465,000 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World
Dyne Therapeutics (NASDAQ:DYN) Shares Down 3% - MarketBeat
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Holdings Boosted by Great Point Partners LLC - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) and Oramed Pharmaceuticals (NASDAQ:ORMP) Financial Review - Defense World
DexCom, Inc. (NASDAQ:DXCM) Shares Sold by Thrivent Financial for Lutherans - MarketBeat
Great Point Partners LLC Boosts Position in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - MarketBeat
Rhumbline Advisers Acquires Shares of 32,138 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
Dropbox CEO Andrew Houston sells shares worth over $87,000 - Investing.com
Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 3.2% - MarketBeat
How does Dianthus Therapeutics Inc (DNTH) change from a tortoise to a hare? - SETE News
Dyne Therapeutics’ (DYN) “Overweight” Rating Reaffirmed at Piper Sandler - Defense World
Incyte Insiders Sold US$4.8m Of Shares Suggesting Hesitancy - Simply Wall St
Victory Capital Management Inc. Takes Position in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Shares Up 7.5% - Defense World
31,047 Shares in Incyte Co. (NASDAQ:INCY) Purchased by XTX Topco Ltd - Defense World
Dianthus Therapeutics (NASDAQ:DNTH) Trading 7.5% Higher - MarketBeat
Dianthus Therapeutics (NASDAQ:DNTH) Trading Down 5.3% - Defense World
WINTON GROUP Ltd Buys Shares of 10,238 Dianthus Therapeutics, Inc. (NASDAQ:DNTH) - Defense World
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - Kilgore News Herald
Dyne Therapeutics director sells over $161k in company stock - Investing.com India
Dyne Therapeutics Inc (DYN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Dianthus Therapeutics Inc (DNTH) 財務データ
収益
当期純利益
現金流量
EPS
2.02%
0.47%
大文字化:
|
ボリューム (24 時間):